Piperazine derivatives as active histamine H3 receptor ligands - molecular modeling, synthesis, pharmacological evaluation

2016/23/N/NZ7/00469

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Katarzyna Anna Szczepańska

Number of co-investigators in the project: 3

Call

PRELUDIUM 12 – announced on 2016-09-15

Amount awarded
141 600 PLN
Project start date
2017-09-01
Project end date
2021-02-28
Project duration
42 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Komputer Dell Inspiron 5477 AiO 23.8".
  2. Notebook Dell Inspiron 5400. Cost: 5 200 PLN

Information in the final report

Publication in academic press/journals (5)

  1. Optimization and preclinical evaluation of novel histamine H3 receptor ligands: Acetyl and propionyl phenoxyalkyl piperazine derivatives

    Authors:
    Katarzyna Szczepańska, Tadeusz Karcz, Magdalena Kotańska, Agata Siwek, Kamil J. Kuder, Gniewomir Latacz, Szczepan Mogilski, Stefanie Hagenow, Annamaria Lubelska, Michał Sobolewski, Holger Stark, Katarzyna Kieć-Kononowicz
    Academic press:
    Bioorganic & Medicinal Chemistry (year: 2018, volume: 26, pages: 6056-6066), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bmc.2018.11.010 – link to the publication
  2. Structural modifications and in vitro pharmacological evaluation of 4-pyridylpiperazine derivatives as an active and selective histamine H3 receptor ligands

    Authors:
    Katarzyna Szczepańska, Tadeusz Karcz, Agata Siwek, Kamil J. Kuder, Gniewomir Latacz, Marek Bednarski, Małgorzata Szafarz, Stefanie Hagenow, Annamaria Lubelska, Agnieszka Olejarz-Maciej, Michał Sobolewski, Kamil Mika, Magdalena Kotańska, Holger Stark, Katarzyna Kieć-Kononowicz
    Academic press:
    Bioorganic Chemistry (year: 2019, volume: 91, pages: 103071), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bioorg.2019.103071 – link to the publication
  3. KSK19 – novel histamine H3 receptor ligand reduces body weight in diet induced obese mice

    Authors:
    Magdalena Kotańska, Kamil Mika, Karolina Reguła, Katarzyna Szczepańska, Małgorzata Szafarz, Marek Bednarski, Agnieszka Olejarz-Maciej, Katarzyna Nowak, Gniewomir Latacz, Szczepan Mogilski, Kamil J. Kuder, Katarzyna Kieć-Kononowicz, Jacek Sapa
    Academic press:
    Biochemical Pharmacology (year: 2019, volume: 168, pages: 193-203), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bcp.2019.07.006 – link to the publication
  4. N-Substituted piperazine derivatives as potential multitarget agents acting on histamine H 3 receptor and cancer resistance proteins

    Authors:
    Katarzyna Szczepańska, Annamária Kincses, Klaudia Vincze, Ewa Szymańska, Gniewomir Latacz, Kamil J Kuder, Holger Stark, Gabriella Spengler, Jadwiga Handzlik, Katarzyna Kieć-Kononowicz
    Academic press:
    Bioorganic & Medicinal Chemistry Letters (year: 2020, volume: 30, pages: 127522), Publisher: Elsevier
    Status:
    Published
    DOI:
    10.1016/j.bmcl.2020.127522 – link to the publication
  5. Dual-targeting Approach on Histamine H3 and Sigma-1 Receptor Ligands as Promising Pharmacological Tools in the Treatment of CNS-linked Disorders

    Authors:
    Katarzyna Szczepańska, Kamil J. Kuder, Katarzyna Kieć-Kononowicz
    Academic press:
    Current Medicinal Chemistry, (year: 2020, volume: 27, pages: 46044), Publisher: Bentham Science
    Status:
    Published
    DOI:
    10.2174/0929867327666200806103144 – link to the publication

Articles in post-conference publications (2)

  1. STRUCTURAL MODIFICATIONS AND PHARMACOLOGICAL EVALUATION OF 4-PYRIDYLPIPERAZINE DERIVATIVES AS ACTIVE AND SELECTIVE HISTAMINE H-3 RECEPTOR LIGANDS

    Authors:
    Katarzyna Szczepanska, Tadeusz Karcz, Kamil J. Kuder, Gniewomir Latacz, Magdalena Kotańska, Stefanie Hagenow, Holger Stark, Katarzyna Kiec-Kononowicz
    Conference:
    The European Histamine Research Society 48th Annual Meeting (year: 2019, pages: 41), Publisher: Springer
    Date:
    conference 15-18.05.2019
    Status:
    Published
  2. NOVEL HISTAMINE H-3 RECEPTOR LIGANDS-EFFECTIVE COMPOUNDS AS POTENTIAL ANTIOBESITY AGENTS

    Authors:
    Kamil Mika, Magdalena Kotańska, Katarzyna Szczepańska, Kamil J. Kuder, Marek Bednarski, Agnieszka Olejarz-Maciej, Małgorzata Szafarz, Krzysztof Pociecha, Agata Siwek, Katarzyna Kieć-Kononowicz
    Conference:
    The European Histamine Research Society 48th Annual Meeting (year: 2019, pages: 33-34), Publisher: Springer
    Date:
    conference 15-18.05.2019
    Status:
    Published

« New search

Graphic design and implementation: Jakub Piotrowski